Latest Insider Transactions at Anika Therapeutics, Inc. (ANIK)
This section provides a real-time view of insider transactions for Anika Therapeutics, Inc. (ANIK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Anika Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Anika Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Anne Nunes SVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
732
-5.15%
|
$17,568
$24.27 P/Share
|
|
Oct 01
2024
|
Anne Nunes SVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,491
+14.91%
|
-
|
|
Jul 09
2024
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+14.62%
|
-
|
|
Jul 09
2024
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+13.8%
|
-
|
|
Jul 09
2024
|
Joseph H Capper Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+48.05%
|
-
|
|
Jul 09
2024
|
Sheryl L Conley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+16.89%
|
-
|
|
Jul 09
2024
|
Gary P Fishetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+17.37%
|
-
|
|
Jul 09
2024
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+13.91%
|
-
|
|
Jul 09
2024
|
William R Jellison Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+48.05%
|
-
|
|
Jul 09
2024
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,771
+13.78%
|
-
|
|
Jun 03
2024
|
Joseph H Capper Director |
BUY
Grant, award, or other acquisition
|
Direct |
468
+50.0%
|
-
|
|
Jun 03
2024
|
William R Jellison Director |
BUY
Grant, award, or other acquisition
|
Direct |
468
+12.87%
|
-
|
|
Mar 11
2024
|
Michael L Levitz EVP, CFO, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,638
-4.26%
|
$140,950
$25.54 P/Share
|
|
Mar 11
2024
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,201
+12.62%
|
-
|
|
Mar 11
2024
|
Anne Nunes SVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,720
-7.9%
|
$43,000
$25.61 P/Share
|
|
Mar 11
2024
|
Anne Nunes SVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,856
+21.06%
|
-
|
|
Mar 11
2024
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,936
-5.41%
|
$123,400
$25.54 P/Share
|
|
Mar 11
2024
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
16,809
+15.52%
|
-
|
|
Mar 11
2024
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
27,980
-6.22%
|
$699,500
$25.54 P/Share
|
|
Mar 11
2024
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
64,480
+12.54%
|
-
|
|
Oct 01
2023
|
Anne Nunes SVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
732
-12.66%
|
$13,176
$18.63 P/Share
|
|
Oct 01
2023
|
Anne Nunes SVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,491
+30.1%
|
-
|
|
Aug 10
2023
|
Michael L Levitz EVP, CFO, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,133
-3.3%
|
$20,394
$18.58 P/Share
|
|
Aug 10
2023
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,859
+10.1%
|
-
|
|
Jun 14
2023
|
Sheryl L Conley Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+22.31%
|
-
|
|
Jun 14
2023
|
Gary P Fishetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+23.07%
|
-
|
|
Jun 14
2023
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.84%
|
-
|
|
Jun 14
2023
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.65%
|
-
|
|
Jun 14
2023
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+18.88%
|
-
|
|
Jun 14
2023
|
Jeffery S Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.07%
|
-
|
|
Jun 14
2023
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.67%
|
-
|
|
Apr 26
2023
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,900
-8.71%
|
$283,400
$26.34 P/Share
|
|
Apr 26
2023
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,575
+16.41%
|
-
|
|
Apr 13
2023
|
Gary P Fishetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,858
+45.86%
|
-
|
|
Mar 10
2023
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
13,211
-11.61%
|
$343,486
$26.1 P/Share
|
|
Mar 10
2023
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,060
+20.9%
|
-
|
|
Mar 10
2023
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2,250
-9.98%
|
$58,500
$26.1 P/Share
|
|
Mar 10
2023
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
7,663
+25.37%
|
-
|
|
Mar 10
2023
|
Michael L Levitz EVP, CFO, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,609
-8.04%
|
$67,834
$26.1 P/Share
|
|
Mar 10
2023
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,888
+21.5%
|
-
|
|
Mar 09
2023
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,232
-4.81%
|
$110,032
$26.91 P/Share
|
|
Mar 09
2023
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,419
+14.08%
|
-
|
|
Mar 09
2023
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,081
-6.77%
|
$28,106
$26.91 P/Share
|
|
Mar 09
2023
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
3,683
+18.75%
|
-
|
|
Mar 09
2023
|
Michael L Levitz EVP, CFO, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,303
-5.24%
|
$33,878
$26.91 P/Share
|
|
Mar 09
2023
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,439
+15.15%
|
-
|
|
Mar 04
2023
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-5.64%
|
$22,754
$31.59 P/Share
|
|
Mar 04
2023
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+16.12%
|
-
|
|
Aug 10
2022
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,859
+15.89%
|
-
|
|
Jun 08
2022
|
Jeffery S Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,954
+24.08%
|
-
|